Ion Suppression
The observed analyte signal is lower than expected because co-eluting matrix components reduce ionization efficiency. This can reduce sensitivity and may contribute to underestimation if not adequately compensated.
Matrix effects occur when components of a biological sample alter the analytical response of a target analyte during LC-MS/MS analysis. These effects can change measured signal intensity and contribute to variability or quantitative bias if they are not appropriately evaluated and controlled.
Biological matrices such as serum, plasma, urine, and whole blood contain proteins, phospholipids, salts, metabolites, lipids, and other endogenous compounds that can influence ionization efficiency.
When matrix components co-elute with the target analyte, they may change the amount of analyte ion formed in the source and therefore alter measured signal.
Matrix effects are typically observed as a decrease or increase in analyte response.
The observed analyte signal is lower than expected because co-eluting matrix components reduce ionization efficiency. This can reduce sensitivity and may contribute to underestimation if not adequately compensated.
The observed analyte signal is higher than expected because the sample environment increases ionization response. This can create positive bias or overestimation if calibration materials behave differently.
The degree of matrix-related interference may vary between individual specimens, matrix lots, and sample types. If the calibration system does not adequately represent that behavior, quantitative performance may be affected.
Matrix effects are observed during ionization, but their magnitude can be influenced by earlier decisions involving specimen type, extraction, cleanup, and chromatography.
Matrix effects cannot always be eliminated completely. The goal is to reduce avoidable interference and design the quantitative system so that calibrators, controls, and unknown samples behave as comparably as practical.
Get the complete guide to matrix effects in LC-MS/MS, including the process diagram, common sources of interference, mitigation strategies, and method-development considerations to keep on file or share with your team.
Related Biomaterial Solutions
Monobind offers human-derived and specialty biological matrices designed to support calibration, quality control, assay development, and analytical validation.
Specialty biological matrices for LC-MS/MS calibration and method development.
Human-derived matrices for research, validation, and assay development.
Specialty fractions for analytical and diagnostic development applications.
Biological urine matrices for research and quantitative assay development.
Tell us your target analyte, matrix type, approximate volume, and application. Our team can help identify an appropriate TrueZero®, specialty, or human biological matrix for evaluation.
This educational resource is intended to support assay developers, clinical laboratories, and research scientists. Biomaterial selection, calibration design, and analytical validation should be based on the specific requirements of each method and its intended use.